Literature DB >> 33735405

In vitro validation and characterization of pulsed inhaled nitric oxide administration during early inspiration.

Philipp A Pickerodt1, Moritz B T Hofferberth2, Thilo Busch2, Martin Russ2, Mahdi Taher2, Willehad Boemke2, Steffen Weber-Carstens2, Rainer Köbrich3, Erik Swenson4,5, Maria Deja6, Roland C E Francis2.   

Abstract

PURPOSE: Admixture of nitric oxide (NO) to the gas inspired with mechanical ventilation can be achieved through continuous, timed, or pulsed injection of NO into the inspiratory limb. The dose and timing of NO injection govern the inspired and intrapulmonary effect site concentrations achieved with different administration modes. Here we test the effectiveness and target reliability of a new mode injecting pulsed NO boluses exclusively during early inspiration.
METHODS: An in vitro lung model was operated under various ventilator settings. Admixture of NO through injection into the inspiratory limb was timed either (i) selectively during early inspiration ("pulsed delivery"), or as customary, (ii) during inspiratory time or (iii) the entire respiratory cycle. Set NO target concentrations of 5-40 parts per million (ppm) were tested for agreement with the yield NO concentrations measured at various sites in the inspiratory limb, to assess the effectiveness of these NO administration modes.
RESULTS: Pulsed delivery produced inspiratory NO concentrations comparable with those of customary modes of NO administration. At low (450 ml) and ultra-low (230 ml) tidal volumes, pulsed delivery yielded better agreement of the set target (up to 40 ppm) and inspiratory NO concentrations as compared to customary modes. Pulsed delivery with NO injection close to the artificial lung yielded higher intrapulmonary NO concentrations than with NO injection close to the ventilator. The maximum inspiratory NO concentration observed in the trachea (68 ± 30 ppm) occurred with pulsed delivery at a set target of 40 ppm.
CONCLUSION: Pulsed early inspiratory phase NO injection is as effective as continuous or non-selective admixture of NO to inspired gas and may confer improved target reliability, especially at low, lung protective tidal volumes.
© 2021. The Author(s).

Entities:  

Keywords:  ARDS; Artificial lung; Inhalation; Mechanical ventilation; Nitric oxide; PiNO

Mesh:

Substances:

Year:  2021        PMID: 33735405      PMCID: PMC7970749          DOI: 10.1007/s10877-021-00689-x

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   1.977


  3 in total

Review 1.  Evidence-based clinical practice guideline: inhaled nitric oxide for neonates with acute hypoxic respiratory failure.

Authors:  Robert M DiBlasi; Timothy R Myers; Dean R Hess
Journal:  Respir Care       Date:  2010-12       Impact factor: 2.258

2.  Dysregulated immunity in SARS-CoV-2 infected pregnant women.

Authors:  Morgan L Sherer; Jun Lei; Patrick Creisher; Minyoung Jang; Ramya Reddy; Kristin Voegtline; Sarah Olson; Kirsten Littlefield; Han-Sol Park; Rebecca L Ursin; Abhinaya Ganesan; Theresa Boyer; Diane M Brown; Samantha N Walch; Annukka A R Antar; Yukari C Manabe; Kimberly Jones-Beatty; William Christopher Golden; Andrew J Satin; Jeanne S Sheffield; Andrew Pekosz; Sabra L Klein; Irina Burd
Journal:  medRxiv       Date:  2020-11-16

3.  Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.

Authors:  Dario Akaberi; Janina Krambrich; Jiaxin Ling; Chen Luni; Göran Hedenstierna; Josef D Järhult; Johan Lennerstrand; Åke Lundkvist
Journal:  Redox Biol       Date:  2020-09-21       Impact factor: 11.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.